Goldman PE arm buys MyEyeDr in $2.7B deal, producing 3.5x return for Altas Partners


optometry, ophthalmology, medical, private equity, vision care, M&A, healthcare, merger, Goldman Sachs, MyEyeDr, retail
Eva-Katalin/E+/Getty Images

To view this content you must sign in:

Not yet registered? Join today to access PE Hub industry insights and updates.